Strata Critical Medical (NASDAQ:SRTA – Get Free Report) CAO Amir Cohen sold 40,575 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $5.91, for a total value of $239,798.25. Following the completion of the sale, the chief accounting officer directly owned 151,263 shares in the company, valued at $893,964.33. This trade represents a 21.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Amir Cohen also recently made the following trade(s):
- On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.79, for a total value of $59,637.00.
Strata Critical Medical Price Performance
NASDAQ:SRTA traded up $0.01 during trading hours on Tuesday, hitting $6.14. The company’s stock had a trading volume of 981,609 shares, compared to its average volume of 869,593. The stock has a fifty day simple moving average of $4.82. The stock has a market capitalization of $531.29 million, a P/E ratio of -76.75 and a beta of 2.15. Strata Critical Medical has a twelve month low of $3.40 and a twelve month high of $6.27.
Wall Street Analyst Weigh In
A number of analysts have recently commented on SRTA shares. B. Riley Financial started coverage on Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target on the stock. Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Craig Hallum assumed coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price target for the company. Finally, Zacks Research upgraded shares of Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Strata Critical Medical presently has a consensus rating of “Moderate Buy” and an average target price of $8.00.
Check Out Our Latest Research Report on SRTA
Hedge Funds Weigh In On Strata Critical Medical
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Granite Investment Partners LLC lifted its stake in shares of Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after acquiring an additional 7,911 shares during the period. Seelaus Asset Management LLC lifted its stake in shares of Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after acquiring an additional 6,000 shares during the period. Principal Financial Group Inc. acquired a new position in shares of Strata Critical Medical in the first quarter worth approximately $537,000. Quantinno Capital Management LP lifted its stake in shares of Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after acquiring an additional 71,155 shares during the period. Finally, Bank of America Corp DE lifted its stake in shares of Strata Critical Medical by 16.2% in the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock worth $759,000 after acquiring an additional 25,379 shares during the period. 47.36% of the stock is owned by institutional investors and hedge funds.
About Strata Critical Medical
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Further Reading
- Five stocks we like better than Strata Critical Medical
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
